novo glp-1 drug inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs Hair loss with GLP-1 drugs

Goncalves JT, Schafer ST, Gage FH (2016) Adult neurogenesis in the hippocampus: from stem cells to behavior

Email [email protected] with the date, location, and a short description of your meetup, wellness chat, or support event, and we'll consider featuring it on this page.

Exenatide showed the highest vomiting incidence

After SARS-CoV-2 infection, the viremia stage could increase OxS, elevated levels of ROS/inflammation markers (i.e., peroxide, NO, carbonylated proteins, and IL-6) and inflict severe cellular/tissue damage

Second, multimodal therapies combining urate-lowering agents, anti-inflammatory cytokines, and immunomodulators within a single platform may synergize to halt disease progression while minimizing systemic side effects